Lista de obras -

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.

artículo científico publicado en 2014

Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation

artículo científico publicado en 2006

Adoptive transfer of rapidly-generated multivirus-specific T cells to treat Adv, EBV, CMV, BK and HHV6 infections of HSCT recipients

artículo científico publicado en 2013

Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients

scientific article published on 01 September 2019

CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo

artículo científico publicado en 2015

Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis

artículo científico publicado en 2004

Children with acute leukemia: A comparison of outcomes from allogeneic blood stem cell and bone marrow transplantation ⬇️

artículo científico publicado el 1 de enero de 2011

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS post-allogeneic transplant

artículo científico publicado en 2020

Comparable outcome of alternative donor and matched sibling donor hematopoietic stem cell transplant for children with acute lymphoblastic leukemia in first or second remission using alemtuzumab in a myeloablative conditioning regimen

artículo científico publicado en 2008

Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia

artículo científico publicado en 2006

Complement-fixing CD45 monoclonal antibodies to facilitate stem cell transplantation in mouse and man.

artículo científico publicado en 2003

Current Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphocytic Leukemia: Success, Failure and Future Perspectives-A Single-Center Experience, 2008 to 2016.

artículo científico publicado en 2018

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

artículo científico publicado en 2009

Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease

artículo científico publicado en 2011

Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cells

artículo científico publicado en 2014

Hematopoietic and immunomodulatory effects of lytic CD45 monoclonal antibodies in patients with hematologic malignancy

artículo científico publicado en 2003

High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease

artículo científico publicado en 2018

Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation.

artículo científico publicado en 2005

Inducible apoptosis as a safety switch for adoptive cell therapy

artículo científico publicado en 2011

Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation

artículo científico publicado en 2015

Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

scientific article published on 12 September 2013

Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene

artículo científico publicado en 2014

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

artículo científico publicado en 2006

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

artículo científico publicado en 2017

Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome

artículo científico publicado en 2017

Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies

artículo científico publicado en 2015

Prompt versus preemptive intervention for EBV lymphoproliferative disease

scientific article published on 29 January 2004

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

artículo científico publicado en 2013

Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine

artículo científico publicado en 2008

Systemic inflammatory response syndrome after administration of unmodified T lymphocytes

artículo científico publicado en 2014

T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor-Expressing T Cells

artículo científico publicado en 2019

The costs and cost-effectiveness of allogeneic peripheral blood stem cell transplantation versus bone marrow transplantation in pediatric patients with acute leukemia

artículo científico publicado en 2010

Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.

artículo científico publicado en 2014

Lista de obras de

Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT.

Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation

Adoptive transfer of rapidly-generated multivirus-specific T cells to treat Adv, EBV, CMV, BK and HHV6 infections of HSCT recipients

Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients

CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo

Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis

Children with acute leukemia: A comparison of outcomes from allogeneic blood stem cell and bone marrow transplantation ⬇️

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS post-allogeneic transplant

Comparable outcome of alternative donor and matched sibling donor hematopoietic stem cell transplant for children with acute lymphoblastic leukemia in first or second remission using alemtuzumab in a myeloablative conditioning regimen

Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia

Complement-fixing CD45 monoclonal antibodies to facilitate stem cell transplantation in mouse and man.

Current Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphocytic Leukemia: Success, Failure and Future Perspectives-A Single-Center Experience, 2008 to 2016.

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease

Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cells

Hematopoietic and immunomodulatory effects of lytic CD45 monoclonal antibodies in patients with hematologic malignancy

High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease

Immunotherapy of high-risk acute leukemia with a recipient (autologous) vaccine expressing transgenic human CD40L and IL-2 after chemotherapy and allogeneic stem cell transplantation.

Inducible apoptosis as a safety switch for adoptive cell therapy

Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation

Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

Long-term outcome after haploidentical stem cell transplant and infusion of T cells expressing the inducible caspase 9 safety transgene

Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome

Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies

Prompt versus preemptive intervention for EBV lymphoproliferative disease

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine

Systemic inflammatory response syndrome after administration of unmodified T lymphocytes

T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor-Expressing T Cells

The costs and cost-effectiveness of allogeneic peripheral blood stem cell transplantation versus bone marrow transplantation in pediatric patients with acute leukemia

Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.